Cargando…
Ubiquitin-conjugating enzyme E2T knockdown suppresses hepatocellular tumorigenesis via inducing cell cycle arrest and apoptosis
BACKGROUND: Hepatocellular carcinoma (HCC) is now the most common primary liver malignancy worldwide, and multiple risk factors attribute to the occurrence and development of HCC. Recently, increasing studies suggest that ubiquitin-conjugating enzyme E2T (UBE2T) serves as a promising prognostic fact...
Autores principales: | Guo, Jian, Wang, Mu, Wang, Jun-Ping, Wu, Chang-Xin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6881511/ https://www.ncbi.nlm.nih.gov/pubmed/31798276 http://dx.doi.org/10.3748/wjg.v25.i43.6386 |
Ejemplares similares
-
Functions of three ubiquitin-conjugating enzyme 2 genes in hepatocellular carcinoma diagnosis and prognosis
por: Zhang, Chun-Ye, et al.
Publicado: (2022) -
Growth arrest-specific gene 2 suppresses hepatocarcinogenesis by intervention of cell cycle and p53-dependent apoptosis
por: Zhu, Ran-Xu, et al.
Publicado: (2019) -
BIR repeat-containing ubiquitin conjugating enzyme (BRUCE) regulation of β-catenin signaling in the progression of drug-induced hepatic fibrosis and carcinogenesis
por: Vilfranc, Chrystelle L, et al.
Publicado: (2021) -
Suppression of colorectal tumorigenesis by recombinant Bacteroides fragilis enterotoxin-2 in vivo
por: Lv, You, et al.
Publicado: (2017) -
Short hairpin RNA-mediated knockdown of nuclear factor erythroid 2-like 3 exhibits tumor-suppressing effects in hepatocellular carcinoma cells
por: Yu, Miao-Mei, et al.
Publicado: (2019)